OBJECTIVE: A multisite evaluation examined the process and outcomes of Advancing Recovery, a Robert Wood Johnson Foundation initiative to overcome barriers to implementing evidence-based treatments within alcohol and drug treatment systems. METHOD: We report findings from a 3-year, mixed-method study of how treatment systems promoted two evidence-based practices: medication-assisted treatment and continuing care management. We compared outcomes and implementation strategies across 12 state/county agencies responsible for alcohol and drug treatment and their selected treatment centers. Each partnership received 2 years of financial and technical support to increase adoption of evidence-based treatments. RESULTS: Partnerships flexibly applied the Advancing Recovery model to promote the adoption of evidence-based treatments. Most sites achieved a measurable increase in the numbers of patients served with evidence-based practices, up from a baseline of virtually no use. Rates of adopting medication-based treatments were higher than those for continuing care management. Partnerships used a menu of top-down and bottom-up strategies that varied in specifics across sites but shared a general process of incremental testing and piecemeal adaptation. CONCLUSIONS: Supported partnerships between providers and policymakers can achieve wider adoption of evidence-based treatment practices. Systems change unfolds through a trial-and-error process of adaptation and political learning that is unique to each treatment system. This leads to considerable state and local variation in implementation strategies and outcomes.
OBJECTIVE: A multisite evaluation examined the process and outcomes of Advancing Recovery, a Robert Wood Johnson Foundation initiative to overcome barriers to implementing evidence-based treatments within alcohol and drug treatment systems. METHOD: We report findings from a 3-year, mixed-method study of how treatment systems promoted two evidence-based practices: medication-assisted treatment and continuing care management. We compared outcomes and implementation strategies across 12 state/county agencies responsible for alcohol and drug treatment and their selected treatment centers. Each partnership received 2 years of financial and technical support to increase adoption of evidence-based treatments. RESULTS: Partnerships flexibly applied the Advancing Recovery model to promote the adoption of evidence-based treatments. Most sites achieved a measurable increase in the numbers of patients served with evidence-based practices, up from a baseline of virtually no use. Rates of adopting medication-based treatments were higher than those for continuing care management. Partnerships used a menu of top-down and bottom-up strategies that varied in specifics across sites but shared a general process of incremental testing and piecemeal adaptation. CONCLUSIONS: Supported partnerships between providers and policymakers can achieve wider adoption of evidence-based treatment practices. Systems change unfolds through a trial-and-error process of adaptation and political learning that is unique to each treatment system. This leads to considerable state and local variation in implementation strategies and outcomes.
Authors: James R McKay; Kevin G Lynch; Donna Coviello; Rebecca Morrison; Mark S Cary; Lauren Skalina; Jennifer Plebani Journal: J Consult Clin Psychol Date: 2010-02
Authors: Raina Croff; Kim Hoffman; Kelly Alanis-Hirsch; Jay Ford; Dennis McCarty; Laura Schmidt Journal: J Behav Health Serv Res Date: 2019-04 Impact factor: 1.505
Authors: Allison G Robertson; Michele M Easter; Hsiu-Ju Lin; Linda K Frisman; Jeffrey W Swanson; Marvin S Swartz Journal: J Subst Abuse Treat Date: 2017-12-12
Authors: Allison G Robertson; Michele M Easter; HsiuJu Lin; Linda K Frisman; Jeffrey W Swanson; Marvin S Swartz Journal: Am J Psychiatry Date: 2018-07-01 Impact factor: 18.112
Authors: James H Ford; Amanda J Abraham; Nicoleta Lupulescu-Mann; Raina Croff; Kim A Hoffman; Kelly Alanis-Hirsch; Mady Chalk; Laura Schmidt; Dennis McCarty Journal: J Stud Alcohol Drugs Date: 2017-09 Impact factor: 2.582
Authors: Helene Chokron Garneau; Mehret T Assefa; Booil Jo; James H Ford; Lisa Saldana; Mark P McGovern Journal: Psychiatr Serv Date: 2021-08-04 Impact factor: 3.084